C. W. STRICKLER JR., M.D., F.A.C.P.; A. PARK MCGINTY, M.D.; JOHN B. PESCHAU JR., M.D.
The intravenous use of sodium sulfapyridine was reported first by Marshall and Long.1 Since the beginning of this study other reports2, 8 on the parenteral use of sodium sulfapyridine for special indications have appeared. In none of these reports has the drug been given routinely and repeatedly. Data obtained from the routine repeated intravenous infusion of sodium sulfapyridine should be valuable in establishing the indications for its use by this route.
This report presents our experience with the intravenous use of sodium sulfapyridine monohydrate in the treatment of 54 patients suffering with lobar pneumonia. The patients in
STRICKLER CW, MCGINTY AP, PESCHAU JB. THE INTRAVENOUS USE OF SODIUM SULFAPYRIDINE IN THE TREATMENT OF LOBAR PNEUMONIA1. Ann Intern Med. ;14:1595–1606. doi: 10.7326/0003-4819-14-9-1595
Download citation file:
Published: Ann Intern Med. 1941;14(9):1595-1606.
Infectious Disease, Pneumonia, Pulmonary/Critical Care.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use